Everpar Advisors LLC Takes Position in Exponent, Inc. (NASDAQ:EXPO)

Everpar Advisors LLC bought a new position in Exponent, Inc. (NASDAQ:EXPOFree Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 6,518 shares of the business services provider’s stock, valued at approximately $574,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in EXPO. Operose Advisors LLC acquired a new position in Exponent in the third quarter worth approximately $39,000. Signaturefd LLC raised its position in shares of Exponent by 157.7% during the third quarter. Signaturefd LLC now owns 915 shares of the business services provider’s stock worth $78,000 after purchasing an additional 560 shares during the period. Parkside Financial Bank & Trust boosted its position in shares of Exponent by 10.5% in the 3rd quarter. Parkside Financial Bank & Trust now owns 1,468 shares of the business services provider’s stock valued at $126,000 after purchasing an additional 140 shares during the period. Covestor Ltd increased its stake in Exponent by 24.8% in the 3rd quarter. Covestor Ltd now owns 1,474 shares of the business services provider’s stock worth $126,000 after purchasing an additional 293 shares in the last quarter. Finally, Quadrature Capital Ltd raised its holdings in Exponent by 6.7% during the 3rd quarter. Quadrature Capital Ltd now owns 2,452 shares of the business services provider’s stock worth $210,000 after buying an additional 155 shares during the period. 92.37% of the stock is owned by institutional investors and hedge funds.

Exponent Stock Performance

Shares of NASDAQ EXPO traded up $0.18 during mid-day trading on Tuesday, reaching $94.68. The company had a trading volume of 271,126 shares, compared to its average volume of 313,207. Exponent, Inc. has a twelve month low of $64.61 and a twelve month high of $102.72. The stock’s 50 day moving average is $82.08 and its 200-day moving average is $82.07. The stock has a market capitalization of $4.79 billion, a PE ratio of 47.82 and a beta of 0.64.

Exponent (NASDAQ:EXPOGet Free Report) last posted its earnings results on Thursday, April 25th. The business services provider reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.13. The company had revenue of $137.21 million for the quarter, compared to analyst estimates of $125.98 million. Exponent had a return on equity of 28.13% and a net margin of 18.72%. The business’s revenue was up 6.6% compared to the same quarter last year. During the same period last year, the company earned $0.56 earnings per share. On average, sell-side analysts anticipate that Exponent, Inc. will post 1.92 EPS for the current year.

Exponent Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 21st. Investors of record on Friday, June 7th will be issued a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 1.18%. The ex-dividend date is Friday, June 7th. Exponent’s dividend payout ratio is currently 56.57%.

Insider Activity at Exponent

In other Exponent news, VP Bradley A. James sold 3,528 shares of the business’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $95.00, for a total transaction of $335,160.00. Following the completion of the transaction, the vice president now owns 2,030 shares of the company’s stock, valued at approximately $192,850. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Exponent news, VP Bradley A. James sold 3,528 shares of Exponent stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $95.00, for a total value of $335,160.00. Following the transaction, the vice president now directly owns 2,030 shares of the company’s stock, valued at approximately $192,850. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Eric Guyer sold 1,650 shares of the company’s stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $92.58, for a total value of $152,757.00. Following the transaction, the insider now owns 1,846 shares of the company’s stock, valued at $170,902.68. The disclosure for this sale can be found here. In the last three months, insiders have sold 8,558 shares of company stock worth $753,402. 2.20% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on EXPO shares. StockNews.com raised shares of Exponent from a “sell” rating to a “hold” rating in a research report on Monday, March 4th. Truist Financial boosted their target price on shares of Exponent from $95.00 to $100.00 and gave the company a “buy” rating in a research note on Monday, April 29th.

Check Out Our Latest Stock Analysis on EXPO

Exponent Company Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Further Reading

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.